# VABOMERE
> **NDA209776** · New Drug Application · Sponsor: REMPEX · Approved 2017-08-29
## Drug
- **FDA Application Number:** NDA209776
- **Application type:** New Drug Application
- **Brand name:** VABOMERE
- **Generic name:** MEROPENEM-VABORBACTAM
- **Active ingredients:** MEROPENEM; VABORBACTAM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** REMPEX
- **Manufacturer:** Melinta Therapeutics, LLC
- **First approval:** 2017-08-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209776)
---
*AI Analytics · CC0 1.0*